Peru Orders Recall, Destruction of QM Pharma's Pantoprazol 40 mg Due to Quality Failures

Peru's health authority, Digemid, has ordered the immediate withdrawal and destruction of all batches of Pantoprazol 40 mg tablets manufactured by QM Pharma. The medication, commonly prescribed for conditions like gastroesophageal reflux and ulcers, has been found to have significant quality deficiencies. Digemid's investigation revealed problems with the drug's dissolution of the active ingredient, which could compromise its therapeutic effectiveness and potentially pose risks to patient health. The agency's decision aims to prevent further distribution and consumption of the substandard medication. Consumers who possess the affected Pantoprazol 40 mg are advised to cease its use immediately. They should contact QM Pharma Quality Medicine S.A.C. directly for guidance on the return process. The company has provided a dedicated phone number, 990 085 619, and an email address, regulatorio@qmpharma.com, for consumer inquiries. Peru's consumer protection agency, Indecopi, also reminded the public about its alert system for reporting products that may pose safety or health risks.

“

The measure seeks to prevent possible risks to the health of those who use this drug.